Analyst Price Target is $73.29
▼ -11.05% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $73.29, with a high forecast of $92.00 and a low forecast of $55.00. The average price target represents a -11.05% upside from the last price of $82.39.
Current Consensus is
Moderate Buy
The current consensus among 7 investment analysts is to moderate buy stock in National Health Investors. This rating has held steady since March 2024, when it changed from a Hold consensus rating.
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More